Schedule 13G ownership disclosure

DBV TECHNOLOGIES SA

Ordinary Shares, EURO0.10 nominal value per share, represented by American Depository Shares · CUSIP: 23306J309

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners II, L.P.

    Shares: 14,286,553.00 · Class: 9.8%

  • VHCP Co-Investment Holdings II, LLC

    Shares: 14,286,553.00 · Class: 9.8%

  • VHCP Management II, LLC

    Shares: 14,286,553.00 · Class: 9.8%

  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 14,286,553.00 · Class: 9.8%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 14,286,553.00 · Class: 9.8%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 14,286,553.00 · Class: 9.8%

  • VHCP Management III, LLC

    Shares: 14,286,553.00 · Class: 9.8%

  • VHCP Management EG, LLC

    Shares: 14,286,553.00 · Class: 9.8%

  • Nimish Shah

    Shares: 14,286,553.00 · Class: 9.8%

  • Bong Y. Koh

    Shares: 14,286,553.00 · Class: 9.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-022017
Form type
SCHEDULE 13G/A
Filer
DBV Technologies S.A.
CIK
CIK 1613780
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub